Pages that link to "Q64378976"
Jump to navigation
Jump to search
The following pages link to Bcl-xl reduces doxorubicin-induced myocardial damage but fails to control cardiac gene downregulation (Q64378976):
Displaying 12 items.
- Stimulation of mitochondrial biogenesis and autophagy by lipopolysaccharide in the neonatal rat cardiomyocyte protects against programmed cell death (Q28577104) (← links)
- Inhibition of apoptosis by progesterone in cardiomyocytes (Q34047552) (← links)
- Dexamethasone induces transcriptional activation of Bcl-xL gene and inhibits cardiac injury by myocardial ischemia (Q34103584) (← links)
- Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment (Q34639876) (← links)
- Oral treatment with the herbal formula B307 alleviates cardiac toxicity in doxorubicin-treated mice via suppressing oxidative stress, inflammation, and apoptosis (Q35679360) (← links)
- Sildenafil augments early protective transcriptional changes after ischemia in mouse myocardium (Q37115656) (← links)
- Distinct mechanisms of cardiomyocyte apoptosis induced by doxorubicin and hypoxia converge on mitochondria and are inhibited by Bcl-xL (Q37580188) (← links)
- Abnormalities in Alternative Splicing of Apoptotic Genes and Cardiovascular Diseases (Q38637311) (← links)
- Cardioprotective effects of sitagliptin against doxorubicin-induced cardiotoxicity in rats (Q39870539) (← links)
- ARC is a critical cardiomyocyte survival switch in doxorubicin cardiotoxicity (Q40010724) (← links)
- Uncoupling protein downregulation in doxorubicin-induced heart failure improves mitochondrial coupling but increases reactive oxygen species generation. (Q41827191) (← links)
- Doxorubicin triggers splenic contraction and irreversible dysregulation of COX and LOX that alters the inflammation-resolution program in the myocardium (Q90738432) (← links)